Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus

Shailesh Nandish, Jamison Wyatt, Oscar Bailon, Mike Smith, Rene A Oliveros, Robert J Chilton

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The role of cardiovascular risk reduction in patients with diabetes mellitus is significant as several factors have been found to promote accelerated atherosclerosis in persons with diabetes including hyperglycemia-induced endothelial dysfunction, impaired fibrinolysis, increased platelet aggregation, plaque instability, dysfunctional arterial remodeling, and fibrotic and calcified coronary arteries. Recent attention has focused on identifying a cardiovascular biomarker that would propose a better noninvasive way to detect or visualize subclinical cardiovascular disease and prevent cardiovascular events. This article reviews the use of commonly used cardiovascular risk assessment tools and emerging biomarkers including coronary artery calcium scanning, metabolomics, genomics, and the role of optimal revascularization and risk reduction strategies and their impact on reducing risk in patients with cardiovascular disease and diabetes.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
Volume108
Issue number3 SUPPL.
DOIs
StatePublished - Aug 2 2011

Fingerprint

Risk Reduction Behavior
Coronary Vessels
Diabetes Mellitus
Cardiovascular Diseases
Biomarkers
Metabolomics
Fibrinolysis
Genomics
Platelet Aggregation
Hyperglycemia
Atherosclerosis
Calcium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. / Nandish, Shailesh; Wyatt, Jamison; Bailon, Oscar; Smith, Mike; Oliveros, Rene A; Chilton, Robert J.

In: American Journal of Cardiology, Vol. 108, No. 3 SUPPL., 02.08.2011.

Research output: Contribution to journalArticle

Nandish, Shailesh ; Wyatt, Jamison ; Bailon, Oscar ; Smith, Mike ; Oliveros, Rene A ; Chilton, Robert J. / Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. In: American Journal of Cardiology. 2011 ; Vol. 108, No. 3 SUPPL.
@article{d2a5e58774c74eefbc4d6ceeddb4abe2,
title = "Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus",
abstract = "The role of cardiovascular risk reduction in patients with diabetes mellitus is significant as several factors have been found to promote accelerated atherosclerosis in persons with diabetes including hyperglycemia-induced endothelial dysfunction, impaired fibrinolysis, increased platelet aggregation, plaque instability, dysfunctional arterial remodeling, and fibrotic and calcified coronary arteries. Recent attention has focused on identifying a cardiovascular biomarker that would propose a better noninvasive way to detect or visualize subclinical cardiovascular disease and prevent cardiovascular events. This article reviews the use of commonly used cardiovascular risk assessment tools and emerging biomarkers including coronary artery calcium scanning, metabolomics, genomics, and the role of optimal revascularization and risk reduction strategies and their impact on reducing risk in patients with cardiovascular disease and diabetes.",
author = "Shailesh Nandish and Jamison Wyatt and Oscar Bailon and Mike Smith and Oliveros, {Rene A} and Chilton, {Robert J}",
year = "2011",
month = "8",
day = "2",
doi = "10.1016/j.amjcard.2011.03.015",
language = "English (US)",
volume = "108",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus

AU - Nandish, Shailesh

AU - Wyatt, Jamison

AU - Bailon, Oscar

AU - Smith, Mike

AU - Oliveros, Rene A

AU - Chilton, Robert J

PY - 2011/8/2

Y1 - 2011/8/2

N2 - The role of cardiovascular risk reduction in patients with diabetes mellitus is significant as several factors have been found to promote accelerated atherosclerosis in persons with diabetes including hyperglycemia-induced endothelial dysfunction, impaired fibrinolysis, increased platelet aggregation, plaque instability, dysfunctional arterial remodeling, and fibrotic and calcified coronary arteries. Recent attention has focused on identifying a cardiovascular biomarker that would propose a better noninvasive way to detect or visualize subclinical cardiovascular disease and prevent cardiovascular events. This article reviews the use of commonly used cardiovascular risk assessment tools and emerging biomarkers including coronary artery calcium scanning, metabolomics, genomics, and the role of optimal revascularization and risk reduction strategies and their impact on reducing risk in patients with cardiovascular disease and diabetes.

AB - The role of cardiovascular risk reduction in patients with diabetes mellitus is significant as several factors have been found to promote accelerated atherosclerosis in persons with diabetes including hyperglycemia-induced endothelial dysfunction, impaired fibrinolysis, increased platelet aggregation, plaque instability, dysfunctional arterial remodeling, and fibrotic and calcified coronary arteries. Recent attention has focused on identifying a cardiovascular biomarker that would propose a better noninvasive way to detect or visualize subclinical cardiovascular disease and prevent cardiovascular events. This article reviews the use of commonly used cardiovascular risk assessment tools and emerging biomarkers including coronary artery calcium scanning, metabolomics, genomics, and the role of optimal revascularization and risk reduction strategies and their impact on reducing risk in patients with cardiovascular disease and diabetes.

UR - http://www.scopus.com/inward/record.url?scp=79961057159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961057159&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2011.03.015

DO - 10.1016/j.amjcard.2011.03.015

M3 - Article

C2 - 21802580

AN - SCOPUS:79961057159

VL - 108

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 3 SUPPL.

ER -